← Back to Search

Other

Cyrolipolysis + Subcision for Cellulite

N/A
Waitlist Available
Led By Murad Alam, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline in cellulite severity scale at 3 months
Awards & highlights

Study Summary

This trial will compare the effectiveness of cryolipolysis (a fat-freezing procedure) to a combination of cryolipolysis and surgical subcision (a procedure that breaks up fibrous connective tissue) for the treatment of cellulite.

Who is the study for?
Healthy women aged 18-65 with noticeable cellulite on both thighs, who can give informed consent. Excluded are those pregnant or breastfeeding, allergic to certain antibiotics or local anesthetics, taking blood thinners, have a coagulation disorder, abnormal scarring history, active skin disease/infection in the area, or cold-induced diseases.Check my eligibility
What is being tested?
The study is testing if cryolipolysis alone or combined with surgical subcision is more effective for treating cellulite. Each participant's one thigh gets cryolipolysis and the other thigh also gets subcision. A dermatologist will rate cellulite severity before treatment and after three months without knowing which thigh received which treatment.See study design
What are the potential side effects?
Cryolipolysis may cause temporary redness, swelling, bruising and pain at the treatment site. Subcision could lead to similar side effects along with potential risk of infection and abnormal scarring due to its surgical nature.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline in cellulite severity scale at 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline in cellulite severity scale at 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Live rating by a blinded dermatologist using cellulite severity scale

Trial Design

2Treatment groups
Active Control
Group I: cryolipolysis plus subcisionActive Control2 Interventions
Group II: cyrolipolysisActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Zeltiq AestheticsIndustry Sponsor
40 Previous Clinical Trials
1,834 Total Patients Enrolled
3 Trials studying Cellulite
134 Patients Enrolled for Cellulite
Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
917,216 Total Patients Enrolled
1 Trials studying Cellulite
22 Patients Enrolled for Cellulite
Murad Alam, MDPrincipal InvestigatorNorthwestern University
69 Previous Clinical Trials
2,565 Total Patients Enrolled
1 Trials studying Cellulite
22 Patients Enrolled for Cellulite

Media Library

Cryolipolysis (Other) Clinical Trial Eligibility Overview. Trial Name: NCT02427698 — N/A
Cellulite Research Study Groups: cryolipolysis plus subcision, cyrolipolysis
Cellulite Clinical Trial 2023: Cryolipolysis Highlights & Side Effects. Trial Name: NCT02427698 — N/A
Cryolipolysis (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02427698 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What site did they apply to?
Northwestern University Feinberg School of Medicine, Department of Dermatology
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
~1 spots leftby Dec 2024